CIRM Funded Clinical Trials

AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205

Disease Area: 
B cell cancers
Investigator:
CIRM Grant:
CLIN2-14302 (Pre-Active)
Award Value:
$15,000,000
Trial Sponsor:
Angiocrine Bioscience, Inc.
Trial Stage: 
Phase 3
Trial Status: 
Recruiting
Targeted Enrollment:
148
ClinicalTrials.gov ID: